Validity of brain MRI as the primary outcome criterion in multiple sclerosis phase II clinical trials.
Liedtke
W
W
Limmroth
V
V
D001921:Brain / Q000473:pathology*; D017322:Clinical Trials, Phase II as Topic / Q000379:methods*; D006801:Humans; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000175:diagnosis* / Q000628:therapy*; D016896:Treatment Outcome